SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

12 Months Ended

Dec. 31, 2020

Accounting Policies [Abstract]

The opening balance of the allowance for doubtful accounts is reconciled to the closing balance for expected credit losses as follows:

The opening balance of the allowance for doubtful accounts is reconciled to the closing balance for expected credit losses as follows:

Allowance for Doubtful Accounts
Balance - January 1, 2020	$	904,040
Increase in allowance		422,137
Recoveries		(181,514	)
Write-offs		(26,809	)
Balance - December 31, 2020	$	1,117,854

The following table provides information about disaggregated revenue, net by product mix for the years ended December 31, 2020, 2019, and 2018:

The following table provides information about disaggregated revenue, net by product mix for the years ended December 31, 2020, 2019, and 2018:

	For the Years Ended December 31,
	2020		2019		2018
Prescription vitamins	$	9,767,644	$	9,885,493	$	15,041,259
IMVEXXY		27,139,387		16,252,045		1,058,201
BIJUVA		6,353,963		1,836,443		—
ANNOVERA		19,611,286		6,166,556		—
License revenue		2,000,000		15,506,400		—
Net revenue	$	64,872,280	$	49,646,937	$	16,099,460

Schedule of calculation of diluted net loss per share allocable to common stockholders

	As of December 31,
	2020		2019		2018
Stock options		23,781,930		25,030,234		20,872,824
Warrants		6,534,687		1,832,571		3,007,571
Performance stock units		2,403,951		—		—
Restricted stock units		7,061,024		1,240,000		1,040,000
		39,781,592		28,102,805		24,920,395